Capital World Investors Amends Tandem Diabetes Stake to 9.9%

Ticker: TNDM · Form: SC 13G/A · Filed: 2024-02-09T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, healthcare, investor-update

TL;DR

**Capital World Investors now owns 9.9% of Tandem Diabetes Care, a notable institutional stake.**

AI Summary

Capital World Investors, a major institutional investor, has updated its holdings in Tandem Diabetes Care Inc. As of December 29, 2023, they beneficially own 6,536,778 shares of common stock, representing 9.9% of the company. This is an amendment to a previous filing, indicating a change in their ownership stake. For investors, this matters because large institutional ownership can signal confidence in a company's long-term prospects, but a reduction could also suggest a shift in sentiment.

Why It Matters

This filing shows a significant institutional investor's updated position in Tandem Diabetes Care, which can influence market perception and stock price due to the sheer volume of shares they hold.

Risk Assessment

Risk Level: low — This filing is a routine update of an institutional investor's holdings and does not inherently signal high risk, though changes in ownership can impact stock sentiment.

Analyst Insight

An investor should note Capital World Investors' continued significant stake (9.9%) in Tandem Diabetes Care, as large institutional ownership can provide a degree of stability and confidence, but also monitor future filings for any substantial changes in their position.

Key Numbers

6,536,778 — Shares Beneficially Owned (This is the total number of Tandem Diabetes Care shares Capital World Investors holds, indicating their significant investment.)
9.9% — Ownership Percentage (This percentage shows Capital World Investors' substantial stake in the company, nearing the 10% threshold often watched by investors.)
December 29, 2023 — Date of Event (This date marks when the ownership change occurred, providing a specific reference point for the reported data.)

Key Players & Entities

Capital World Investors (company) — the reporting person and institutional investor
Tandem Diabetes Care Inc. (company) — the subject company whose shares are being reported
6,536,778 (dollar_amount) — number of shares beneficially owned by Capital World Investors
9.9% (dollar_amount) — percentage of Tandem Diabetes Care Inc. common stock owned by Capital World Investors
December 29, 2023 (date) — the date of the event requiring this filing

Forward-Looking Statements

Capital World Investors will maintain a significant stake in Tandem Diabetes Care Inc. above 5% for the next year. (Capital World Investors) — high confidence, target: December 29, 2024

FAQ

Who is the reporting person in this SC 13G/A filing?

The reporting person is Capital World Investors, as stated in the 'NAMES OF REPORTING PERSONS' section and the 'FILED BY' section of the filing.

What is the subject company whose shares are being reported?

The subject company is Tandem Diabetes Care, Inc., as indicated in the 'Name of Issuer' section and the 'SUBJECT COMPANY' data.

How many shares of Tandem Diabetes Care Inc. common stock does Capital World Investors beneficially own?

Capital World Investors beneficially owns 6,536,778 shares of Tandem Diabetes Care Inc. common stock, as reported under 'AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON'.

What percentage of Tandem Diabetes Care Inc.'s common stock does Capital World Investors own?

The filing indicates that Capital World Investors owns 9.9% of Tandem Diabetes Care Inc.'s common stock, derived from the aggregate amount beneficially owned.

What was the date of the event that required this Schedule 13G/A filing?

The date of the event which required the filing of this statement was December 29, 2023, as specified in the 'Date of Event Which Requires Filing of this Statement' section.

From the Filing

0001422848-24-000296.txt : 20240209 0001422848-24-000296.hdr.sgml : 20240209 20240209182127 ACCESSION NUMBER: 0001422848-24-000296 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87718 FILM NUMBER: 24616840 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Capital World Investors CENTRAL INDEX KEY: 0001422849 ORGANIZATION NAME: IRS NUMBER: 951411037 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90071 SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 ) * Tandem Diabetes Care, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 875372203 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 875372203 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors 95-1411037 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 6,510,923 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 6,536,778 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,536,778 Beneficial ownership disclaimed pursuant to Rule 13d-4 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.0% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer Tandem Diabetes Care, Inc. (b) Address of Issuer's Principal Executive Offices 12400 High Bluff Drive, San Diego, CA 92130 Item 2. (a) Name of Person Filing Capital World Investors (b) Address of Principal Business Office or, if None, Residence 333 SOUTH HOPE STREET, 55TH FLOOR, LOS ANGELES, CALIFORNIA 90071 (c) Citizenship N/A (d) Title of Class of Securities Common Stock (e) CUSIP Number 875372203 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in Section 3(a)(19) of